Stockscreener 앱 받기
2.57
0.00%
0.00
시간 외 거래:
2.49
-0.08
-3.11%
전일 마감가:
$2.57
열려 있는:
$2.6089
하루 거래량:
55,048
Relative Volume:
0.37
시가총액:
$35.37M
수익:
$1.93M
순이익/손실:
$-3.10M
주가수익비율:
-0.157
EPS:
-16.3657
순현금흐름:
$-1.93M
1주 성능:
-7.22%
1개월 성능:
-43.02%
6개월 성능:
-59.64%
1년 성능:
-81.43%
1일 변동 폭
$2.41
$2.67
1주일 범위
$2.41
$2.8822
52주 변동 폭
$2.40
$26.96
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
명칭
China Sxt Pharmaceuticals Inc
전화
-
주소
-
SXTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.57 | 35.37M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
163.46 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.97 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.38B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
0.00 | 14.05B | 612.78M | -86.37M | -62.91M | -0.87 |
China Sxt Pharmaceuticals Inc 주식(SXTC)의 최신 뉴스
China SXT Pharmaceuticals Reports Financial Results Amid Regulatory Challenges - TipRanks
China SXT Pharmaceuticals regains compliance with Nasdaq’s minimum bid price deficiency - MSN
China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange - TipRanks
China SXT Pharmaceuticals Regains Compliance With Nasdaq's Minimum Bid Price Requirement - Nasdaq
China SXT Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements - Nasdaq
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency - GlobeNewswire
China SXT Successfully Averts Nasdaq Delisting Through Strategic 1-for-8 Share Consolidation - StockTitan
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 1,448.9% in February - Defense World
Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn
Stock market news: China SXT Pharmaceuticals plummented by 92.58% while Wah Fu Education Group skyrocketed by 78.37% during midday trading - Business Upturn
Stock market today: China SXT Pharmaceuticals -93.05%, Comstock -90.24% among biggest losers in early trading - Business Upturn
Stock market today: China SXT Pharmaceuticals plunged by 92.61% while Wah Fu Education Group surged by 239.75% in early trading - Business Upturn
SXTC stock touches 52-week high of $3.95 amid market fluctuations - Investing.com India
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
China SXT Pharmaceuticals announces 1-for-8 share consolidation - Investing.com
China SXT Pharmaceutics, Inc. Announces 1-for-8 Share Consolidation to Regain Nasdaq Compliance - Nasdaq
China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewswire
Will SXTC's Share Consolidation Save Its Nasdaq Listing? Key Dates Revealed - StockTitan
China SXT Pharmaceuticals Announces New Securities Purchase Agreement - MSN
China SXT Pharmaceuticals, Inc. announced that it expects to receive $2.84 million in funding - Marketscreener.com
China SXT Pharmaceuticals, Inc. Announces CEO Changes -January 23, 2025 at 04:15 pm EST - Marketscreener.com
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Before Buying China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock, Read This First - Stocks Register
China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Up 1.5% – Should You Buy? - Defense World
SXTC stock hits 52-week low at $0.36 amid sharp annual decline - Investing.com
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Inkl
SXTC stock hits 52-week low at $0.37 amid sharp annual decline - Investing.com Australia
SXTC stock hits 52-week low at $0.43 amid sharp annual decline - Investing.com Australia
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com India
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
In the Green: China SXT Pharmaceuticals Inc (SXTC) Closes at 0.63, Up/Down 12.64 from Previous Day - The Dwinnex
SXTC’s Stock Market Adventure: -84.07% YTD Growth Amidst Volatility - The InvestChronicle
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
SXTC’s Market Whiplash: -83.70% YTD Decline, -22.51% Plunge in 30 Days - The InvestChronicle
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
China SXT Pharmaceuticals: Operational Risks and Profit Repatriation Challenges - TipRanks
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - markets.businessinsider.com
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule - Yahoo Finance
China SXT Pharma (NASDAQ: SXTC) to jump 2,500%a purely technical move - Dhaka Tribune
China SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5 - Nasdaq
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today? - InvestorPlace
China Sxt Pharmaceuticals Inc (SXTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.37%
0.54%
자본화:
|
볼륨(24시간):